KORU Medical Systems, Inc. (KRMD): Capital Expenditures

Annual figures by period end, from SEC filings.

$932.5K
Year ended 2025-12-31
$614.3K
Trailing 12 months to 2026-06-30
-30.4%
3-year compound annual growth
+0.3%
5-year compound annual growth
$2.76M2018-12-31: $297.0K2019-12-31: $201.2K2020-12-31: $920.6K2021-12-31: $346.2K2022-12-31: $2.76M2023-12-31: $782.9K2024-12-31: $1.30M2025-12-31: $932.5K$932.5K
2018-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$932.5K-28.1%2026-03-12, From 2025-01-01
2024-12-31$1.30M+65.7%2026-03-12, From 2024-01-01
2023-12-31$782.9K-71.6%2025-03-12, From 2023-01-01
2022-12-31$2.76M+697.6%2024-03-13, From 2022-01-01
2021-12-31$346.2K-62.4%2023-03-08, From 2021-01-01
2020-12-31$920.6K+357.6%2022-03-02, From 2020-01-01
2019-12-31$201.2K-32.3%2021-03-23, From 2019-01-01
2018-12-31$297.0Kn/a2020-03-04, From 2018-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
KORU Medical Systems, Inc. (KRMD)2025-12-31$932.5K-28.1%
SS Innovations International, Inc. (SSII)2025-12-31$3.66M+453.2%
Interpace Biosciences, Inc. (IDXG)2025-12-31$356.0K-59.4%
Utah Medical Products Inc (UTMD)2025-12-31$371.0K+61.3%
SANUWAVE Health, Inc. (SNWV)2025-12-31$1.94M+296.3%
Retractable Technologies Inc (RVP)2024-12-31$1.44M+68.8%
TriSalus Life Sciences, Inc. (TLSI)2025-12-31$918.0K+166.1%
Cytosorbents Corp (CTSO)2025-12-31$164.0K-42.3%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$522.0K+89.8%

Compare KRMD, SSII, IDXG, UTMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗